Trials / Completed
CompletedNCT00105456
A Study of Patients With HER2-Positive Metastatic Breast Cancer
registHER: An Observational Cohort Study of Patients With HER2 Positive Metastatic Breast Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (planned)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a prospective observational cohort study designed to describe effectiveness and safety (treatment outcomes and clinically significant cardiac adverse events, respectively) in patients with HER2-positive metastatic breast cancer.
Conditions
Timeline
- Start date
- 2003-03-01
- Completion
- 2009-05-01
- First posted
- 2005-03-15
- Last updated
- 2010-05-06
Source: ClinicalTrials.gov record NCT00105456. Inclusion in this directory is not an endorsement.